BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33718371)

  • 1. Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy.
    Conte E; Pannunzio A; Imbrici P; Camerino GM; Maggi L; Mora M; Gibertini S; Cappellari O; De Luca A; Coluccia M; Liantonio A
    Front Cell Dev Biol; 2021; 9():635063. PubMed ID: 33718371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ORAI1 channel gating and selectivity is differentially altered by natural mutations in the first or third transmembrane domain.
    Bulla M; Gyimesi G; Kim JH; Bhardwaj R; Hediger MA; Frieden M; Demaurex N
    J Physiol; 2019 Jan; 597(2):561-582. PubMed ID: 30382595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy.
    Böhm J; Chevessier F; Maues De Paula A; Koch C; Attarian S; Feger C; Hantaï D; Laforêt P; Ghorab K; Vallat JM; Fardeau M; Figarella-Branger D; Pouget J; Romero NB; Koch M; Ebel C; Levy N; Krahn M; Eymard B; Bartoli M; Laporte J
    Am J Hum Genet; 2013 Feb; 92(2):271-8. PubMed ID: 23332920
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Silva-Rojas R; Laporte J; Böhm J
    Front Physiol; 2020; 11():604941. PubMed ID: 33250786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca
    Riva B; Pessolano E; Quaglia E; Cordero-Sanchez C; Bhela IP; Topf A; Serafini M; Cox D; Harris E; Garibaldi M; Barresi R; Pirali T; Genazzani AA
    Cell Calcium; 2022 Jul; 105():102605. PubMed ID: 35636153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidants restore store-operated Ca
    Sakai-Takemura F; Saito F; Nogami K; Maruyama Y; Elhussieny A; Matsumura K; Takeda S; Aoki Y; Miyagoe-Suzuki Y
    FASEB Bioadv; 2023 Nov; 5(11):453-469. PubMed ID: 37936920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diseases caused by mutations in ORAI1 and STIM1.
    Lacruz RS; Feske S
    Ann N Y Acad Sci; 2015 Nov; 1356(1):45-79. PubMed ID: 26469693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of STIM1/ORAI1-mediated store-operated Ca
    Michelucci A; García-Castañeda M; Boncompagni S; Dirksen RT
    Cell Calcium; 2018 Dec; 76():101-115. PubMed ID: 30414508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ORAI1 Mutations with Distinct Channel Gating Defects in Tubular Aggregate Myopathy.
    Böhm J; Bulla M; Urquhart JE; Malfatti E; Williams SG; O'Sullivan J; Szlauer A; Koch C; Baranello G; Mora M; Ripolone M; Violano R; Moggio M; Kingston H; Dawson T; DeGoede CG; Nixon J; Boland A; Deleuze JF; Romero N; Newman WG; Demaurex N; Laporte J
    Hum Mutat; 2017 Apr; 38(4):426-438. PubMed ID: 28058752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubular aggregate myopathy and Stormorken syndrome: Mutation spectrum and genotype/phenotype correlation.
    Morin G; Biancalana V; Echaniz-Laguna A; Noury JB; Lornage X; Moggio M; Ripolone M; Violano R; Marcorelles P; Maréchal D; Renaud F; Maurage CA; Tard C; Cuisset JM; Laporte J; Böhm J
    Hum Mutat; 2020 Jan; 41(1):17-37. PubMed ID: 31448844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubular aggregate myopathy caused by a novel mutation in the cytoplasmic domain of STIM1.
    Okuma H; Saito F; Mitsui J; Hara Y; Hatanaka Y; Ikeda M; Shimizu T; Matsumura K; Shimizu J; Tsuji S; Sonoo M
    Neurol Genet; 2016 Feb; 2(1):e50. PubMed ID: 27066587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analyses of STIM1 mutations reveal a common pathomechanism for tubular aggregate myopathy and Stormorken syndrome.
    Peche GA; Spiegelhalter C; Silva-Rojas R; Laporte J; Böhm J
    Neuropathology; 2020 Dec; 40(6):559-569. PubMed ID: 33073872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant mutations in ORAI1 cause tubular aggregate myopathy with hypocalcemia via constitutive activation of store-operated Ca²⁺ channels.
    Endo Y; Noguchi S; Hara Y; Hayashi YK; Motomura K; Miyatake S; Murakami N; Tanaka S; Yamashita S; Kizu R; Bamba M; Goto Y; Matsumoto N; Nonaka I; Nishino I
    Hum Mol Genet; 2015 Feb; 24(3):637-48. PubMed ID: 25227914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain-of-function mutations in STIM1 and ORAI1 causing tubular aggregate myopathy and Stormorken syndrome.
    Böhm J; Laporte J
    Cell Calcium; 2018 Dec; 76():1-9. PubMed ID: 30243034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voluntary wheel running mitigates disease in an Orai1 gain-of-function mouse model of tubular aggregate myopathy.
    O'Connor TN; Zhao N; Orciuoli HM; Brasile A; Pietrangelo L; He M; Groom L; Leigh J; Mahamed Z; Liang C; Malik S; Protasi F; Dirksen RT
    bioRxiv; 2023 Sep; ():. PubMed ID: 37808709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological Effects of Overactive STIM1 on Murine Muscle Function and Structure.
    Silva-Rojas R; Charles AL; Djeddi S; Geny B; Laporte J; Böhm J
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Store-operated calcium entry: From physiology to tubular aggregate myopathy.
    Protasi F; Girolami B; Roccabianca S; Rossi D
    Curr Opin Pharmacol; 2023 Feb; 68():102347. PubMed ID: 36608411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STIM1 over-activation generates a multi-systemic phenotype affecting the skeletal muscle, spleen, eye, skin, bones and immune system in mice.
    Silva-Rojas R; Treves S; Jacobs H; Kessler P; Messaddeq N; Laporte J; Böhm J
    Hum Mol Genet; 2019 May; 28(10):1579-1593. PubMed ID: 30576443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of the Ca
    Silva-Rojas R; Pérez-Guàrdia L; Lafabrie E; Moulaert D; Laporte J; Böhm J
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805973
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.